Solifenacin Succinate Tablet, Film Coated
Product Images NDC 35561-285

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Solifenacin Succinate (NDC 35561-285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bostal Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg 30ct Carton Apm

This is a description of a pharmaceutical product. The name of the medication is Solifenacin Succinate and it is available in tablet form with a dosage of 10mg. The tablets do not have any coating. The product is only available on prescription. The rest of the text consists of alphanumeric codes and technical information which is not relevant to the description.*

FDA Label Image

10mg 500ct Bottle Apm

FDA Label Image

10mg 90ct Bottle Apm

FDA Label Image

5mg 30ct Carton Apm

This is a description of a medication called Solifenacin Succinate in tablet form with a dosage of 5mg per tablet. The packaging appears to indicate that there is no coating on the tablets.*

FDA Label Image

5mg 500ct Bottle Apm

Solifenacin Succinate is a medication that comes in the form of tablets and is meant to be taken once daily. The NDC number for this particular medication is 35561-285-13, and it is produced by a company called RxOnly. Unfortunately, the rest of the text is not readable.*

FDA Label Image

5mg 90ct Bottle Apm

Solifenacin Succinate Tablets with NDC 35561-285-11 provided. No other useful information present.*

FDA Label Image

Structure-solifenacin (Structure Solifenacin)

This is a chemical formula representing two molecules, HOOCCH and CHaCOOH. The output is not readable and contains non-English characters.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.